Market Drivers and Challenges for Genome-Based Drugs: 2034 Forecast
The genome-based drug industry is transforming modern healthcare by enabling highly targeted therapies based on an individual's genetic profile. Advances in genomic science and molecular diagnostics are creating new possibilities for treating complex and inherited diseases. Growing adoption of precision medicine, increased investment in biotechnology research, and rapid developments in gene...
0 Comments
0 Shares
68 Views